BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vitiello GA, Miller G. Targeting the interleukin-17 immune axis for cancer immunotherapy. J Exp Med 2020;217:e20190456. [PMID: 31727783 DOI: 10.1084/jem.20190456] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu W, Li Z, He W, Yu D, Wang P, Cai L, Yang P, Chen X, Zhang X, Zhou H. Impact of chemotherapy on lymphocytes and serological memory in recovered COVID-19 patients with acute leukemia. J Cancer 2021;12:2450-5. [PMID: 33758621 DOI: 10.7150/jca.53863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol 2022. [PMID: 35790881 DOI: 10.1038/s41577-022-00746-9] [Reference Citation Analysis]
3 Ghilas S, Mielke LA. Dendritic cells shape TCF1+CD8+ progenitor T cell heterogeneity. Trends Immunol 2021;42:1063-5. [PMID: 34774417 DOI: 10.1016/j.it.2021.10.013] [Reference Citation Analysis]
4 Bellone M, Brevi A, Huber S. Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer. Microbiol Mol Biol Rev 2020;84:e00064-19. [PMID: 32132244 DOI: 10.1128/MMBR.00064-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
5 Lin A, Zhang H, Meng H, Deng Z, Gu T, Luo P, Zhang J. TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. Front Immunol 2021;12:667875. [PMID: 34603277 DOI: 10.3389/fimmu.2021.667875] [Reference Citation Analysis]
6 Accogli T, Bruchard M, Végran F. Modulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment. Cancers (Basel) 2021;13:373. [PMID: 33498483 DOI: 10.3390/cancers13030373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Lambert JLW, Segaert S, Ghislain PD, Hillary T, Nikkels A, Willaert F, Lambert J, Speeckaert R. Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2). J Eur Acad Dermatol Venereol 2020;34:1914-23. [PMID: 32791572 DOI: 10.1111/jdv.16683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Bechara R, McGeachy MJ, Gaffen SL. The metabolism-modulating activity of IL-17 signaling in health and disease. J Exp Med 2021;218:e20202191. [PMID: 33822846 DOI: 10.1084/jem.20202191] [Reference Citation Analysis]
9 Lee KL, Lai TC, Wang YC, Shih PC, Yang YC, Tsao TC, Liu TC, Wen YC, Chang LC, Yang SF, Chien MH. Potential Impacts of Interleukin-17A Promoter Polymorphisms on the EGFR Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan. Genes (Basel) 2021;12:427. [PMID: 33802737 DOI: 10.3390/genes12030427] [Reference Citation Analysis]
10 Li H, Zhang J, An C, Dong S. Probing N -Glycan Functions in Human Interleukin-17A Based on Chemically Synthesized Homogeneous Glycoforms. J Am Chem Soc 2021;143:2846-56. [DOI: 10.1021/jacs.0c12448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Nicola S, Ridolfi I, Rolla G, Filosso P, Giobbe R, Boita M, Culla B, Bucca C, Solidoro P, Brussino L. IL-17 Promotes Nitric Oxide Production in Non-Small-Cell Lung Cancer. J Clin Med 2021;10:4572. [PMID: 34640589 DOI: 10.3390/jcm10194572] [Reference Citation Analysis]
12 Miller J, Puravath AP, Orbai AM. Ixekizumab for Psoriatic Arthritis: Safety, Efficacy, and Patient Selection. J Inflamm Res 2021;14:6975-91. [PMID: 34949934 DOI: 10.2147/JIR.S229752] [Reference Citation Analysis]
13 López-Cantillo G, Urueña C, Camacho BA, Ramírez-Segura C. CAR-T Cell Performance: How to Improve Their Persistence? Front Immunol 2022;13:878209. [PMID: 35572525 DOI: 10.3389/fimmu.2022.878209] [Reference Citation Analysis]
14 Soloff AC, Jones KE, Powers AA, Murthy P, Wang Y, Russell KL, Byrne-Steele M, Lund AW, Yuan JM, Monaco SE, Han J, Dhupar R, Lotze MT. HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions. Front Immunol 2020;11:2027. [PMID: 33013860 DOI: 10.3389/fimmu.2020.02027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li Z, Zhang X, Liu C, Ma J. Non-immune Cell Components in the Gastrointestinal Tumor Microenvironment Influencing Tumor Immunotherapy. Front Cell Dev Biol 2021;9:729941. [PMID: 34722510 DOI: 10.3389/fcell.2021.729941] [Reference Citation Analysis]
16 Lin X, Wang L, Xie X, Qin Y, Xie Z, Ouyang M, Zhou C. Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma. Front Mol Biosci 2020;7:602328. [PMID: 33330629 DOI: 10.3389/fmolb.2020.602328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liu T, Zong S, Jiang Y, Zhao R, Wang J, Hua Q. Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway. J Immunol Res 2021;2021:8078646. [PMID: 34938816 DOI: 10.1155/2021/8078646] [Reference Citation Analysis]
18 Liu S, Meng Y, Liu L, Lv Y, Yu W, Liu T, Wang L, Mu D, Zhou Q, Liu M, Ren Y, Zhang D, Li B, Sun Q, Ren X. CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer. Cell Death Dis 2022;13:441. [PMID: 35523765 DOI: 10.1038/s41419-022-04882-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Brevi A, Cogrossi LL, Grazia G, Masciovecchio D, Impellizzieri D, Lacanfora L, Grioni M, Bellone M. Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer. Front Immunol 2020;11:565470. [PMID: 33244315 DOI: 10.3389/fimmu.2020.565470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 Florencia Soler M, del Carmen Bravo-miana R, María Negretti-borga D, Subirada P, Alejandra Alamino V, Cecilia Sánchez M, Carolina Donadio A, Gabriela Pellizas C, del Mar Montesinos M. Triiodothyronine-stimulated dendritic cell vaccination boosts antitumor immunity against murine colon cancer. International Immunopharmacology 2022;110:109016. [DOI: 10.1016/j.intimp.2022.109016] [Reference Citation Analysis]
21 Zare R, Mohtasham N, Ghazi N, Mosannen Mozafari P, Abdollahpoor M, Poursheikhani A, Mohajertehran F, Esmaeilzadeh A. Evaluation of correlation between transcription factors and IL-17 in oral and cutaneous lichen planus lesions and Leukocytes. Cytokine 2021;148:155696. [PMID: 34509039 DOI: 10.1016/j.cyto.2021.155696] [Reference Citation Analysis]
22 Wu Q, Dong W, Miao H, Wang Q, Dong S, Xuan W. Site‐Specific Protein Modification with Reducing Carbohydrates. Angewandte Chemie 2022;134. [DOI: 10.1002/ange.202116545] [Reference Citation Analysis]
23 Lin A, Qiu Z, Zhang J, Luo P. Effect of NCOR1 Mutations on Immune Microenvironment and Efficacy of Immune Checkpoint Inhibitors in Patient with Bladder Cancer. Front Immunol 2021;12:630773. [PMID: 33763074 DOI: 10.3389/fimmu.2021.630773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bai J, Chen H, Bai X. Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment. J Clin Lab Anal 2021;35:e23810. [PMID: 33938589 DOI: 10.1002/jcla.23810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Nagaoka K, Shirai M, Taniguchi K, Hosoi A, Sun C, Kobayashi Y, Maejima K, Fujita M, Nakagawa H, Nomura S, Kakimi K. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. J Immunother Cancer 2020;8:e001358. [PMID: 33093158 DOI: 10.1136/jitc-2020-001358] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
26 Oh DY, Fong L. Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox. Immunity 2021;54:2701-11. [PMID: 34910940 DOI: 10.1016/j.immuni.2021.11.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Shenderov E, Boudadi K, Fu W, Wang H, Sullivan R, Jordan A, Dowling D, Harb R, Schonhoft J, Jendrisak A, Carducci MA, Eisenberger MA, Eshleman JR, Luo J, Drake CG, Pardoll DM, Antonarakis ES. Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial. Prostate 2021;81:326-38. [PMID: 33636027 DOI: 10.1002/pros.24110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 Briukhovetska D, Dörr J, Endres S, Libby P, Dinarello CA, Kobold S. Interleukins in cancer: from biology to therapy. Nat Rev Cancer 2021;21:481-99. [PMID: 34083781 DOI: 10.1038/s41568-021-00363-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
29 Hu C, Xu B, Wang X, Wan WH, Lu J, Kong D, Jin Y, You W, Sun H, Mu X, Feng D, Chen Y. Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC. Hepatology 2022. [PMID: 35262957 DOI: 10.1002/hep.32449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Mills KHG. Innate lymphoid cells recruit T cells to turn up the heat on tumors. Cancer Cell 2022:S1535-6108(22)00117-9. [PMID: 35334205 DOI: 10.1016/j.ccell.2022.03.002] [Reference Citation Analysis]
31 Liu N, Jiang F, Ye M, Wang B, Ge D, Chang S. HuR confers IL-17a-induced migration and invasion of gastric cancer cells via upregulation of Snail translation. Cytokine 2022;153:155830. [PMID: 35247650 DOI: 10.1016/j.cyto.2022.155830] [Reference Citation Analysis]
32 Agerholm R, Bekiaris V. Evolved to protect, designed to destroy: IL-17-producing γδ T cells in infection, inflammation, and cancer. Eur J Immunol 2021;51:2164-77. [PMID: 34224140 DOI: 10.1002/eji.202049119] [Reference Citation Analysis]
33 Flores-Villanueva P, Sobhani N, Wang X, Li Y. MR1-Restricted T Cells in Cancer Immunotherapy. Cancers (Basel) 2020;12:E2145. [PMID: 32756356 DOI: 10.3390/cancers12082145] [Reference Citation Analysis]
34 Li S, Na R, Li X, Zhang Y, Zheng T. Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer. Biochim Biophys Acta Rev Cancer 2022;1877:188758. [PMID: 35809762 DOI: 10.1016/j.bbcan.2022.188758] [Reference Citation Analysis]
35 Trošelj KG, Samaržija I, Tomljanović M, Kujundžić RN, Đaković N, Mojzeš A. Implementing Curcumin in Translational Oncology Research. Molecules 2020;25:E5240. [PMID: 33182817 DOI: 10.3390/molecules25225240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Chen N, Wan G, Zeng X. Integrated Whole-Transcriptome Profiling and Bioinformatics Analysis of the Polypharmacological Effects of Ganoderic Acid Me in Colorectal Cancer Treatment. Front Oncol 2022;12:833375. [PMID: 35574354 DOI: 10.3389/fonc.2022.833375] [Reference Citation Analysis]
37 O'Neill C, Cassidy FC, O'Shea D, Hogan AE. Mucosal Associated Invariant T Cells in Cancer-Friend or Foe? Cancers (Basel) 2021;13:1582. [PMID: 33808058 DOI: 10.3390/cancers13071582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Yang Y, Wang Y. Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment. Front Immunol 2021;12:640369. [PMID: 33868269 DOI: 10.3389/fimmu.2021.640369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Wager K, Chari D, Ho S, Rees T, Penner O, Schijvenaars BJ. Identifying and Validating Networks of Oncology Biomarkers Mined From the Scientific Literature. Cancer Inform 2022;21:117693512210864. [DOI: 10.1177/11769351221086441] [Reference Citation Analysis]
40 Chen SY, Chen S, Feng W, Li Z, Luo Y, Zhu X. A STING-related prognostic score predicts high-risk patients of colorectal cancer and provides insights into immunotherapy. Ann Transl Med 2021;9:14. [PMID: 33553307 DOI: 10.21037/atm-20-2430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Lin A, Zhang J, Luo P. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer. Front Immunol 2020;11:2039. [PMID: 32903444 DOI: 10.3389/fimmu.2020.02039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]